View in EDS HTML Full Text PDF Full Text

Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.

Saved in:
Bibliographic Details
Title: Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.
Authors: Nikitas J; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Holzgreve A; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; and., Juarez J; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Kimura K; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Lira S; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Alam H; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Contreras M; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Theus L; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Nguyen AT; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Ells Z; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Zhu S; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Grogan T; Department of Medicine Statistics Core, UCLA, Los Angeles, California., Elashoff DA; Department of Medicine Statistics Core, UCLA, Los Angeles, California., Unterrainer LM; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; and., Dahlbom M; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Allen-Auerbach M; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Czernin J; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California., Calais J; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California; jcalais@mednet.ucla.edu.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 674-680. Date of Electronic Publication: 2026 May 01.
Publication Type: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41679923
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 2 Prospective Trial of Retreatment with [<superscript>177</superscript>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nikitas+J%22">Nikitas J</searchLink>; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Holzgreve+A%22">Holzgreve A</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; and.<br /><searchLink fieldCode="AU" term="%22Juarez+J%22">Juarez J</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Kimura+K%22">Kimura K</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Lira+S%22">Lira S</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Alam+H%22">Alam H</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Contreras+M%22">Contreras M</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Theus+L%22">Theus L</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Nguyen+AT%22">Nguyen AT</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Ells+Z%22">Ells Z</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Zhu+S%22">Zhu S</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Grogan+T%22">Grogan T</searchLink>; Department of Medicine Statistics Core, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Elashoff+DA%22">Elashoff DA</searchLink>; Department of Medicine Statistics Core, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Unterrainer+LM%22">Unterrainer LM</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; and.<br /><searchLink fieldCode="AU" term="%22Dahlbom+M%22">Dahlbom M</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Allen-Auerbach+M%22">Allen-Auerbach M</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Czernin+J%22">Czernin J</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Calais+J%22">Calais J</searchLink>; Ahmanson Translational Theranostics Division, UCLA, Los Angeles, California; jcalais@mednet.ucla.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 674-680. <i>Date of Electronic Publication: </i>2026 May 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41679923
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.125.271231
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 674
    Titles:
      – TitleFull: Phase 2 Prospective Trial of Retreatment with [177Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nikitas J
      – PersonEntity:
          Name:
            NameFull: Holzgreve A
      – PersonEntity:
          Name:
            NameFull: Juarez J
      – PersonEntity:
          Name:
            NameFull: Kimura K
      – PersonEntity:
          Name:
            NameFull: Lira S
      – PersonEntity:
          Name:
            NameFull: Alam H
      – PersonEntity:
          Name:
            NameFull: Contreras M
      – PersonEntity:
          Name:
            NameFull: Theus L
      – PersonEntity:
          Name:
            NameFull: Nguyen AT
      – PersonEntity:
          Name:
            NameFull: Ells Z
      – PersonEntity:
          Name:
            NameFull: Zhu S
      – PersonEntity:
          Name:
            NameFull: Grogan T
      – PersonEntity:
          Name:
            NameFull: Elashoff DA
      – PersonEntity:
          Name:
            NameFull: Unterrainer LM
      – PersonEntity:
          Name:
            NameFull: Dahlbom M
      – PersonEntity:
          Name:
            NameFull: Allen-Auerbach M
      – PersonEntity:
          Name:
            NameFull: Czernin J
      – PersonEntity:
          Name:
            NameFull: Calais J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1